NCT05458050

Brief Summary

A double blind, non randomized, multicenter investigation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
433

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2022

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 14, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 24, 2023

Completed
Last Updated

August 25, 2023

Status Verified

August 1, 2023

Enrollment Period

10 months

First QC Date

June 15, 2022

Last Update Submit

August 24, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of pressure ulcers developed between visit 1 and 2

    This outcome is to evaluate if the subjects that have been assessed as at risk of developing pressure ulcers (using PU sensor) have actually developed pressure ulcers with a greater probability than those assessed as not at risk

    Up to 4 weeks

Secondary Outcomes (1)

  • Incidence of adverse events (AEs) and adverse device effects (ADEs)

    Up to 2 days

Other Outcomes (4)

  • Proportion of pressure ulcers located in sacrum

    Up to 4 weeks

  • Combine Norton/RAPS with PU Sensor results

    Up tp 4 weeks

  • Compare PU sensor examinations for different skin types

    Up to 4 weeks

  • +1 more other outcomes

Study Arms (1)

PU Sensor examination

OTHER

Device:PU Sensor will assess the microcirculation in sacrum with and without pressure (subject will lay on side and after that on back) the total measurement time is 5-10 minutes

Device: PU sensor

Interventions

PU sensorDEVICE

Device to assess microcirculation in sacrum area to find subjects at risk for pressure ulcer

PU Sensor examination

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Given their written consent to participate in the study
  • Male or female between ≥18 years and ≤ 64 years with a reduced mobility, where the hospitalization may involve a risk that the person may become less active or Male or female ≥65 years

You may not qualify if:

  • Existing pressure ulcer or damage to the skin around the sacrum where the PU sensor plate and pillow are to be placed
  • Fever ≥38 ºC, within 30 minutes before the examination with PU sensor
  • Difficulty lying still in supine position during the examination with PU sensor, which takes 5 to 10 minutes
  • Known allergy or sensitivity to any of the materials in PU sensor that gets in contact with the skin on the sacrum
  • Body weight ≥200 kg
  • Previous participation in the study
  • Mental inability, or language difficulties that results in difficulty to understand the meaning of participation in the study and / or signing the study consent,
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Länssjukhuset Ryhov, Geriatriska kliniken

Jönköping, 55185, Sweden

Location

Oskarhamns Sjukhus

Oskarshamn, 57251, Sweden

Location

Medicin-Geriatriska kliniken Akademiska sjukhuset,

Uppsala, 75185, Sweden

Location

MeSH Terms

Conditions

Pressure Ulcer

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Anna-Christina Ek, RN,PhD

    PU Sensor

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
The medical device will give an ID number but the results from the measurement will be masked until data base is locked (DBL). The data from the measurement will be available after DBL
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Double blind
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2022

First Posted

July 14, 2022

Study Start

September 1, 2022

Primary Completion

June 30, 2023

Study Completion

August 24, 2023

Last Updated

August 25, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Due to uncertainties in EU data protection legislation individual deidentified participant data are not shared. The main uncertainty is the concept of what "deidentified" means. It appears not to mean that the data set of a person is simply separated from the person's name. What additional operations have to be done appears to depend on technological capabilities to re-identify the persons associated with the data set. A common perception is that the technological capabilities for re-identification are permanently increasing. This could have the effect that public data sets that are regarded as deidentified now might become re-identifiable data sets in the future. Once this happens, the sponsor is no longer able to make the publication of the data sets un-happen. This could result in punishment by EU data protection authorities. The sponsor wants to avoid this.

Locations